US CDC Expands Use of Bivalent COVID-19 Vaccines to Kids above 6 months
The use of bivalent COVID-19 vaccines that target both the original COVID-19 virus and Omicron sub-variants, has been expanded to include children aged 6 months to 5 years by the US CDC. The expansion comes a day after the US Food and Drug Administration (FDA) approved the bilvalent COVID-19 vaccine shots developed by Pfizer/BioNTech as […]
Continue Reading